These include the effects on prostate cancer cells of SLC-0111 alone or in combination with daunorubicin [184], radiobiological effects of CA IX inhibition in human breast cancer cells [185], microvascular endothelial cell pH regulation [186], glycolysis and migration suppression in pulmonary microvascular endothelial cells [187], and the involvement of CA isoforms in mitochondrial biogenesis and in the control of lactate production in human Sertoli cells [188]. Here, CA9 is linked to breast cancer.